Somatostatin-receptor scintigraphy in primary breast cancer

The Lancet

Volumn 343, Issue 8898, 1994, Pages 640-643

  van Eijck, C H J ^a   Jeekel, J ^a   Krenning, E P ^a   Bootsma, A ^a   Lamberts, S W J ^a   Oei, H Y ^a   Lindemans, J ^a   van Pel, R ^b   Reubi, J C ^c  

^a ERASMUS UNIVERSITY ROTTERDAM   (Netherlands)

^b ERASMUS MEDICAL CENTER   (Netherlands)

^c UNIVERSITY OF BERN   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

INDIUM 111; OCTREOTIDE; PENTETIC ACID DERIVATIVE; SOMATOSTATIN RECEPTOR; TUMOR MARKER;

ADULT; AGED; ARTICLE; BREAST CANCER; CONTROLLED STUDY; DIAGNOSTIC VALUE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; METASTASIS; PRIORITY JOURNAL; SCINTIGRAPHY;

EID: 0028226562     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(94)92637-9     Document Type: Article

References (25)

1. Hormone-producing gatrointestinal tumors contain high density of somatostein receptors.
2. Somatostatin receptors in human endocrine tumors
3. Distribution of somatostatin receptors in normal and tumor tissue
4. Distribution of somatostatin receptors in the human brain: an autoradiographic study
5. Distribution and biochemical characterization of somatostatin receptors in tumors of the human central nervous system
6. Somatostatin receptor incidence and distribution in breast cancer using receptor autoradiography relationship of EGF receptor
7. 6]-luteinizing-hormone-releasing hormone, somatostatin, epidermal growth factor and sex steroids in 500 biopsy samples of human breast cancer
8. Correlative study on neuro-endocrine differentiation and presence of somatostatin receptors in breast carcinomas
9. Relationship between somatostatin, EGF- and steroid-hormone-receptors in breast cancer
10. Direct inhibitory effects of somatostatin (analog) on the growth of human breast-cancer cells
11. Inhibition of growth of human breast carcinoma in vivo by somatostatin analog SMS 201-995: treatment of nude mouse exenografts
12. Localization of endocrine related tumors with radioiodinated analog of somatostatin
13. Treatment with sandostatin and in vivo localization of tumors with radiolabeled somatostatin analog
14. Parallel in vivo and in vitro detection of functional somatostatin receptors in human endocrine pancreatic tumors: consequences with regards to diagnosis, localization and therapy
15. Somatostatin receptor imaging in the localization of endocrine tumors
16. 3] octreotide: the Rotterdam experience with more than 1000 patients
17. Chromogranin reactive endocrine cells in argyrophilic carcinomas ("carcinoids") and normal tissue of the breast
18. 1]-octreotide, a potential radiopharmaceutical for imaging of somatostatin receptor positive tumours: synthesis, radiolabelling and in vitro validation
19. Een overzicht van de epidemiologie van borstkanker in Nederland
20. Prognostic value of receptors for insulin-like growth factor 1, somatostatin and epidermal growth factor in human breast cancer
21. Comparison of circulating CA 15-3 and carcino embryonic antigen levels in patients with breast cancer
22. Circulating tumor marker levels in advanced breast carcinoma correlate with the extent of metastatic disease
23. Synthesis of somatostatin by breast cancer cells and their inhibition by exogenous somatostatin and sandostatin
24. Antiproliferative effects of somatostatin and the somatostatin analog SMS 201-995 on three human breast-cancer cell lines
25. Growth inhibition of MTX mammary carcinoma by enhancing programmed cell death (apoptosis) with analog of LH-RH and somatostatin